Ignite Creation Date:
2024-05-05 @ 11:28 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00052455
Status:
COMPLETED
Last Update Posted:
2013-12-18
First Post:
2003-01-24
Brief Title:
Temozolomide Compared to Procarbazine Lomustine and Vincristine in Treating Patients With Recurrent Malignant Glioma
Sponsor:
Institute of Cancer Research United Kingdom
Organization:
National Cancer Institute NCI
Organization Data
Organization:
National Cancer Institute NCI
Class:
NIH
Study ID:
CDR0000258428
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Institute of Cancer Research United Kingdom
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None